{"id":"4b4def26-5306-4c0c-a4a8-a3672c7faf56","name":"Omnicell","slug":"omnicell","description":"Omnicell, Inc. (NASDAQ: OMCL) is an American healthcare technology company specializing in medication management automation. Founded in 1992 by Randall Lipps and headquartered in Cranberry Township, Pennsylvania, Omnicell provides the [XR2 Automated Central Pharmacy System](/models/omnicell-xr2), automated dispensing cabinets, and IV compounding robots to hospitals and health systems. The company reported $1.185 billion in revenue for fiscal year 2025 and serves thousands of hospitals and pharmacies across North America.","status":"active","founded":1992,"hq":"Cranberry Township, Pennsylvania, USA","hqLat":40.7099343,"hqLng":-80.1060506,"hqGeocodedAt":"2026-08-05T14:42:00.617Z","hqAddress":null,"hqPrecision":null,"website":"omnicell.com","fundingTotal":null,"type":"hardware","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.omnicell.com/central-pharmacy/xr2/","title":"Omnicell XR2 pharmacy robot"},{"url":"https://www.omnicell.com/","label":"Omnicell — Official Website","title":"Omnicell — Official Website","mediaType":"article","sourceName":"Omnicell (official)"},{"url":"https://ir.omnicell.com/news/news-details/2026/Omnicell-Announces-Fiscal-Year-and-Fourth-Quarter-2025-Financial-Results/default.aspx","label":"Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results","title":"Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results","mediaType":"article","sourceName":"Omnicell IR"}],"keyFacts":[{"label":"Ticker","value":"NASDAQ: OMCL"},{"label":"Revenue","value":"1.185 billion USD FY2025"},{"label":"Clients","value":"Thousands of hospitals and pharmacies across North America"},{"label":"Product portfolio","value":"XR2 Central Pharmacy System, automated dispensing cabinets, i.v.STATION, Medimat"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":"OMCL","stockExchange":"NASDAQ","secCik":"0000926326","revenueUsd":"1185000000","revenueBasis":"reported","revenueAsOf":"2025-12-31T12:00:00.000Z","employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-24T04:35:20.917Z","updatedAt":"2026-08-05T14:47:57.241Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/omnicell","url":"https://registry.deploy.report/companies/omnicell","name":"Omnicell","description":"Omnicell, Inc. (NASDAQ: OMCL) is an American healthcare technology company specializing in medication management automation. Founded in 1992 by Randall Lipps and headquartered in Cranberry Township, Pennsylvania, Omnicell provides the [XR2 Automated Central Pharmacy System](/models/omnicell-xr2), automated dispensing cabinets, and IV compounding robots to hospitals and health systems. The company reported $1.185 billion in revenue for fiscal year 2025 and serves thousands of hospitals and pharmacies across North America.","identifier":"4b4def26-5306-4c0c-a4a8-a3672c7faf56","foundingDate":"1992","address":"Cranberry Township, Pennsylvania, USA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":["primary-academic-peer-reviewed","primary-company-ir"]}}}